Vyleesi (bremelanotide)

**Product type:** Human Prescription Drug

**Active ingredient:** BREMELANOTIDE ACETATE

**Strength:** 1.75 mg/.3mL

**Dosage form:** Injection

**Route:** Subcutaneous

**Labeler:** Palatin Technologies

**Marketing category:** NDA (NDA210557)

**Pharmacologic class:** Melanocortin Receptor Agonist [EPC], Melanocortin Receptor Agonists [MoA]